In memory
What Walter Payton's Story Can Help Us Understand About Bile Duct Cancer
The Hall of Fame running back died of bile duct cancer (cholangiocarcinoma) in 1999. Here is what that diagnosis means, explained calmly and simply.
Please note: this page is educational only — it is not medical advice, and it does not speculate about anyone’s health beyond reliable public reporting. For questions about your own health, talk with your healthcare team.
On screen and in the news
Walter Payton, the Chicago Bears Hall of Fame running back known as "Sweetness," publicly shared in 1999 that he had a serious liver condition, and it was later reported that he had developed bile duct cancer. He died in November 1999 at age 45. His illness was widely followed and reported at the time.
That is what was publicly shared. We share it with respect and do not speculate about any private details of his diagnosis or care.
The reality
According to the National Cancer Institute, bile duct cancer — also called cholangiocarcinoma — is a rare disease in which cancer cells form in the bile ducts. The bile ducts are a network of tubes that connect the liver, gallbladder, and small intestine and carry bile, a fluid the liver makes to help digest fats.
NCI explains there are two main types: intrahepatic bile duct cancer, which forms in the bile ducts inside the liver, and extrahepatic bile duct cancer, which forms in the bile ducts outside the liver. NCI notes that signs and symptoms can include jaundice (yellowing of the skin or the whites of the eyes), dark urine, pain in the abdomen, itchy skin, and unexplained weight loss — though these can also be caused by other conditions. A care team uses staging to understand a cancer and to discuss options.
What the story gets right — and what to remember
Payton chose to speak publicly about his illness and to raise awareness, which many people found moving. His story is a reminder that serious illness can affect people who seem remarkably strong, and that every person's diagnosis and circumstances are different. A public figure's experience is not medical advice or a prediction for anyone else.
Awareness, screening & prevention
NCI notes there are no routine screening tests to check for bile duct cancer before signs and symptoms occur. It has information on causes and risk factors, and lists symptoms — such as jaundice and abdominal pain — that are worth bringing to a healthcare professional. People with certain chronic liver or bile duct conditions may have a different conversation with their care team about risk and monitoring.
Turning a story into something useful
Remembering someone through learning is a gentle way to honor their story. Understanding what bile duct cancer is, knowing the symptoms NCI describes, and learning that support is a real part of care are calm, useful takeaways. Supporting free, trustworthy cancer education helps make that information available to others facing hard news.
Questions to ask a healthcare team
- Is the bile duct cancer being discussed intrahepatic or extrahepatic, and what does its stage mean?
- Which of my symptoms are worth investigating further?
- What are the goals of the options you are describing?
- What emotional and practical support is available for me and my family?